Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
20/20 Healthcare Partners
AddedFeb 15, 2024
UpdatedJun 28, 2026
20/20 Healthcare Partners

20/20 Healthcare Partners

Operating

20/20 Healthcare Partners LLC: A global investment firm specializing in tech and life science startups.

Location
Auburndale, MA, US
Founded
2005
Firm
Compare
Portfolio
Employees
Website

20/20 Healthcare Partners is a global investment firm that focuses on early-stage technology and life science startups. The firm typically invests in companies during Series A, Series C, and other unspecified rounds, providing the necessary capital to help these startups accelerate their growth. Their investment strategy is geared towards innovative companies that can benefit from their strategic advice and domain expertise.

Notable portfolio companies include Coagulo Medical Technologies, EnClear Therapies, PhysIQ, SQZ Biotechnologies, and Variantyx. The firm prides itself on offering value beyond capital, leveraging a proven track record and deep industry experience to support the growth of their investments. Their investment philosophy emphasizes creating value through strategic partnerships and comprehensive support, ensuring that portfolio companies receive not just funding but also critical guidance and expertise.

20/20 Healthcare Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments12
Current Portfolio Count8
Total Portfolio Exits1

Top Investment Stages

Series Unknown7 (58.3%)
Series A3 (25.0%)
Series C2 (16.7%)

Stage Mix

Series Unknown 58%Series A 25%Series C 17%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Variantyx logo

Variantyx

Coagulo Medical Technologies logo

Coagulo Medical Technologies

Vrhealth logo

Vrhealth

EnClear Therapies logo

EnClear Therapies

Verseau Therapeutics logo

Verseau Therapeutics

SQZ Biotechnologies logo

SQZ Biotechnologies

PhysIQ logo

PhysIQ

Qbotix logo

Qbotix

Velocomp logo

Velocomp

Zixi logo

Zixi

20/20 Healthcare Partners - Classification

Also Known As
  • 20/20 Healthcare Partners LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
ISIC
  • 8690Other human health activities
Show 12 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621600Home Health Care Services
  • 621610Home Health Care Services
  • 620000Health Care and Social Assistance
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 623000Nursing and Residential Care Facilities
SIC
  • 8080Home Health Care Services
  • 8082Home Health Care Services
  • 6000Depository Institutions
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified